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Although the bovine tuberculosis (TB) agent,Mycobacterium bovis,
may infect humans and cause disease, long-term epidemiological
data indicate that humans represent a spill-over host in which in-
fection with M. bovis is not self-maintaining. Indeed, human-to-
human transmission of M. bovis strains and other members of
the animal lineage of the tubercle bacilli is very rare. Here, we
report on three mutations affecting the two-component virulence
regulation system PhoP/PhoR (PhoPR) inM. bovis and in the closely
linked Mycobacterium africanum lineage 6 (L6) that likely account
for this discrepancy. Genetic transfer of these mutations into the
human TB agent, Mycobacterium tuberculosis, resulted in down-
regulation of the PhoP regulon, with loss of biologically active lip-
ids, reduced secretion of the 6-kDa early antigenic target (ESAT-6),
and lower virulence. Remarkably, the deleterious effects of the
phoPR mutations were partly compensated by a deletion, specific
to the animal-adapted and M. africanum L6 lineages, that restores
ESAT-6 secretion by a PhoPR-independent mechanism. Similarly,
we also observed that insertion of an IS6110 element upstream
of the phoPR locus may completely revert the phoPR-bovis–associ-
ated fitness loss, which is the case for an exceptional M. bovis
human outbreak strain from Spain. Our findings ultimately explain
the long-term epidemiological data, suggesting that M. bovis and
related phoPR-mutated strains pose a lower risk for progression to
overt human TB, with major impact on the evolutionary history
of TB.
evolution | phylogeny | adaptation | zoonosis
Tuberculosis (TB) is caused by bacilli from the geneticallycompact Mycobacterium tuberculosis complex (MTBC), which
gathers eight defined phylogenetic lineages in addition to the more
distantly related Mycobacterium canettii group (1–3): M. tubercu-
losis sensu-stricto from lineages L1–L4 and L7 form a large group
of human-adapted strains responsible for the vast majority of
global human TB cases, whereas Mycobacterium africanum lin-
eages (L5, L6), which are restricted to humans fromWest Africa,
are phylogenetically linked with the eighth lineage, comprising
the various animal-adapted strains, with Mycobacterium bovis as
the most downstream member in the phylogeny (Fig. 1A) (4, 5).
Animal strains exhibit a wide host range that includes livestock
animals in close contact with humans. Episodes of bovine TB in
cattle herds have been reported in 128 of 155 countries during
the period 2005–2008 (6). Although the bulk of these episodes is
mainly found in developing countries (6), bovine TB remains a
major problem even in some industrialized countries, best ex-
emplified by the United Kingdom, which has experienced an
important resurgence of bovine TB since the 1980s (7). Because
M. bovis and other closely related animal-adapted strains are also
capable of causing TB in humans, this situation raises concerns
regarding the zoonotic risk. Indeed, human TB cases resulting from
M. bovis are estimated to be around 2% worldwide (8), with higher
incidence (18–30% of TB cases) in some developing countries, such
as Tanzania (9). Despite this globally large number of cases, several
lines of evidence suggest that M. bovis and phylogenetically related
strains do not exhibit the same virulence and transmissibility for the
human host asM. tuberculosis sensu-stricto. First, there are very few
reports of human-to-human transmission ofM. bovis. The infection
occurs mostly through consumption of unpasteurized milk or close
contact with infected animals (6, 10) suggesting that M. bovis ex-
hibits a lower transmissibility among humans than M. tuberculosis
sensu-stricto. Second, an important population study in Denmark
showed that morbidity was much lower among patients infected
with M. bovis than M. tuberculosis (11). Because human-to-human
transmission is associated with overt disease, this conclusion is
consistent with a lower transmissibility. Third, isolates from lineage
L6) (also namedWest African 2 and corresponding to one group of
M. africanum strains), which are very closely related phylogeneti-
cally to the strains of the animal lineage, exhibit features suggesting
that they are also less virulent than M. tuberculosis sensu-stricto.
M. africanum strains are restricted to West Africa and, despite
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major population movements between this geographic area and the
rest of the world, they have failed to disseminate worldwide. This
observation has fueled speculations about a potential local zoonotic
reservoir (12). Moreover, an epidemiological study showed that
household contacts of TB patients progress less frequently to active
disease when they are infected with M. africanum L6 than with
M. tuberculosis sensu-stricto (13, 14), a situation similar to that ob-
served for M. bovis (11). Consistently, M. africanum L6 strains ex-
hibit a lower fitness than M. tuberculosis sensu-stricto in the mouse
model of TB (15). Collectively, these observations infer that animal-
adapted strains, along with relatedM. africanum L6 members, have
acquired mutations that affect their fitness for humans. However,
the nature of the genetic differences explaining these specific phe-
notypic traits has remained unknown. Identifying these alterations
and their molecular consequences is of tremendous importance
to understanding the critically relevant factors determining trans-
mission efficiency and host-specific adaptation. This information is
also highly relevant to evaluate the risk associated with the various
MTBC strains.
In the present study, we combined comparative genomics, mo-
lecular genetics, and virulence tests to explore the impact of three
SNPs evolutionarily conserved in animal-adapted andM. africanum
L6 strains. These mutations affect a two-component regulation
system known for its deep impact on the virulence of M. tubercu-
losis. Our findings establish that these SNPs impair the production
and secretion of major protein- and lipid-virulence determinants
and ultimately provide the likely genetic mechanism responsible for
the lower prevalence and virulence of these lineages in humans.
Results and Discussion
SNPs Specific to the Animal and M. africanum Lineages Impair the
Function of PhoPR. Through genome comparison of 30 MTBC
strains, we identified three SNPs affecting the phoPR genes of
members of the animal-adapted and M. africanum L6 lineages
that were not seen in the M. tuberculosis sensu-stricto genomes
(Fig. 1A and Fig. S1). The phoPR genes encode a two-compo-
nent regulatory system that is known for its strong impact on
virulence and immunogenicity ofM. tuberculosis (16, 17) because
of its key role in the regulation of lipid synthesis and secretion of
the 6-kDa secreted antigenic target ESAT-6 (18–22). To explore
whether these SNPs affect the expression of the PhoP regulon,
we first compared the transcriptome of M. tuberculosis strains
lacking the endogenous phoPR genes (ΔphoPR) and their com-
plemented derivatives expressing either the M. bovis or M. tuber-
culosis allele of phoPR (phoPR-bovis and phoPR-TB, respectively).
These comparisons were performed in parallel in M. tuberculosis
strains from two distinct genetic backgrounds: strain GC1237 from
L2 (also named East Asia or Beijing cluster) and the reference
strain H37Rv from L4 (also named Euro-American cluster) (Fig.
1A). In both genetic backgrounds, most genes of the PhoP regulon
(i.e., genes differentially expressed between the WT and corre-
sponding ΔphoPR variant) exhibited clear expression differences
between the phoPR-bovis and phoPR-TB complemented strains
(Fig. 1B and Fig. S2A), a finding confirmed by quantitative
RT-PCR (qRT-PCR) (Fig. 1C and Fig. S2B). This observation is
highly relevant for pathogenicity because PhoPR controls the
synthesis and export of many M. tuberculosis virulence factors,
such as LipF, ESAT-6, and lipids of the polyacyltrehalose (PAT)
Fig. 1. The phoPR allele from animal-adapted andM. africanum L6 strains is deficient. (A) Schematic global phylogenetic tree of the MTBC (1, 2). The length of
the branches does not correlate with phylogenetic distance. Names of the strains used in this study are indicated. (B) Genome-wide transcriptional profiles of
WT M. tuberculosis H37Rv, ΔphoPR mutant, and phoPR-bovis– or phoPR-TB–complemented strains. Fold-change values from individual probes for each gene
were averaged. Those genes showing a statistically significant average fold-change > 2 or < 0.5 in theWT or the phoPR-TB–complemented strains relative to the
ΔphoPRmutant were selected as positively or negatively regulated by PhoP, respectively. (C) qRT-PCR analysis of expression of main reporter genes of the PhoP
regulon. (D) TLC analysis of lipids extracted from [14C] propionic acid-labeled cultures. The position of the major SL (the tetra-acylated sulfoglycolipids, Ac4SGL) is
highlighted (arrow). (E) Immunoblot of secreted and whole-cell fractions probed with ESAT-6– or GroEL2- (used as a lysis control) specific antibodies.
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and sulfolipid (SL) families (18, 19, 23–25). Consistently, the
M. tuberculosis-specific lipids, PAT and SL, were barely detectable
in the ΔphoPR and the phoPR-bovis–complemented mutants rel-
ative to WT or phoPR-TB–complemented strains (Fig. 1D and Fig.
S2C). Similarly, export of ESAT-6 was strongly dependent on the
presence of phoPR-TB allele in the M. tuberculosis WT and
recombinant strains (Fig. 1E and Fig. S2D).
To define which mutation impairs the function of the phoPR-
bovis allele, we first compared the production of PhoP in WT,
ΔphoPR, or complemented strains carrying the phoPR-bovis
or phoPR-TB allele (Fig. S3). A similar amount of the PhoP
protein was detected in the WT and the complemented strains,
suggesting that the SNP located in the promoter region of the
phoPR-bovis allele does not impair the expression of the phoPR
operon. We next produced two phoPR allele chimeras combining
phoP-bovis, carrying the promoter SNP, with phoR-TB (phoP-
bovis+phoR-TB) or phoR-bovis, harboring the missense muta-
tion, with phoP-TB (phoP-TB+phoR-bovis). These chimeras were
used to complement the ΔphoPR mutant. Both the qRT-PCR
and lipid analyses demonstrated that the phoR-bovis allele is
defective, whereas the promoter mutation seems to have no
impact on its own (Fig. S3).
SNPs in the phoPR-bovis Allele Impact Virulence in M. tuberculosis.
Next, we assessed whether the modulation of the PhoP regulon,
caused by the SNPs in the phoPR-bovis allele, affects host–
pathogen interaction. M. tuberculosis is an intracellular pathogen
that thrives inside macrophages and other phagocytes in infected
individuals. Therefore, we first infected human primary macro-
phages with the different recombinant strains and monitored the
intracellular bacterial load at various time points postinfection.
This experiment revealed a lower bacterial load at 6 d post-
infection for the M. tuberculosis mutants expressing the phoPR-
bovis allele relative to its phoPR-TB counterpart (Fig. 2A), a
defect similar to that of the ΔphoPR mutant. We also conducted
low-dose intranasal infection of immunocompetent BALB/c
mice (200 cfu per mouse) using theM. tuberculosisH37Rv strains
carrying the phoPR-TB or phoPR-bovis allele, as well as WT and
ΔphoPR strains as controls. We found that complementation
with the phoPR-bovis allele only partially restored the capacity of
the recombinant H37Rv strain to multiply in infected animals, in
contrast to the strain with the phoPR-TB allele (Fig. 2 B and C).
Thus, the SNPs in the phoPR-bovis allele transferred to M. tu-
berculosis attenuate its virulence both in human cells and in the
mouse infection model.
The PhoPR System Is Defective in Animal-Adapted and M. africanum
L6 Strains But Compensatory Evolution Has Restored ESAT-6 Secretion.
Given the strong phenotype of the phoPR-bovis allele in M. tu-
berculosis sensu-stricto, we sought to determine whether the
phoPR-bovis allele is indeed responsible for an impaired PhoPR
regulation in the M. bovis and M. africanum L6 genetic back-
grounds. To this end, representative strains of these lineages were
transformed with the phoPR-TB allele and assessed for the
expression levels of genes from the PhoP regulon by qRT-PCR.
Expression of indicator genes pks3, pks2, lipF, fadD21, and narK1
was much stronger in M. bovis and M. africanum recombinants
expressing phoPR-TB compared with strains expressing phoPR-
bovis only (Fig. 3A and Fig. S4A). Consistently, lipids (i.e., SL and
PAT) described as specific for M. tuberculosis sensu-stricto (26)
were now detectable in the recombinantM. bovis andM. africanum
strains carrying the phoPR-TB allele, as demonstrated by thin-layer
chromatography (TLC) and mass spectrometry of the purified
compounds (Fig. 3B and Figs. S4 and S5). These findings indicate
the direct link between the phoPR mutations and the lipid profile
of various tubercle bacilli. In contrast, ESAT-6 was secreted at
comparable levels in WT and recombinant strains (Fig. 3C and Fig.
S6), suggesting that the animal-adapted and M. africanum L6 line-
ages have evolved to retain ESAT-6 secretion despite the mutations
in phoPR.
Secretion of ESAT-6 requires the espACD operon (27, 28),
which is part of the PhoP regulon (18, 20–22). In addition to
PhoPR, several regulators, such as the nucleoid-associated pro-
teins Lsr2 (29) and EspR (30–32) and the two-component sys-
tem MprAB (33), were found to modulate the transcription of
the espACD operon in response to environmental signals and
stresses. Interestingly, both animal-adapted andM. africanum L6
strains harbor a specific deletion, named region of difference
8 (RD8) (34), and several SNPs just upstream of espACD relative
to M. tuberculosis sensu-stricto strains (Fig. 4A). The RD8 de-
letion removes binding sites for EspR and MprAB, and therefore
may impact the expression of espACD. These observations led us
to assess espACD gene expression in a collection of animal-
adapted or M. africanum L6 strains and compare it to M. tu-
berculosis sensu-stricto WT or recombinant strains. We found
unexpected high levels of espACD expression in all animal-
adapted orM. africanum L6 strains, in contrast to the situation in
M. tuberculosis ΔphoPR or recombinant strains expressing phoPR-
bovis (Fig. S7), suggesting that espACD expression escaped the
PhoPR control in these strains. This exceptional result was con-
firmed in ΔphoPRmutants of representatives of the animal-adapted
and M. africanum L6 strains showing no reduction of the transcript
level relative to WT, in contrast to M. tuberculosis or M. canettii
Fig. 2. The phoPR-bovis allele impacts the interaction of M. tuberculosis with cellular or animal hosts. (A) Quantification of intracellular bacteria at 24-, 72-,
or 144-h postinfection. Human-monocyte-derived macrophages (hMDM) were infected (at a multiplicity of infection of 2) for 2 h with indicated strains. Data
are mean ± SD of three independent experiments performed in duplicate. (B and C ) Seven-week-old BALB/c mice were infected intranasally with ∼200
cfu of the indicated strains. At the indicated time points, lungs (B) or spleens (C) were homogenized and plated for colony-forming unit determination. Data
are means ± SD of four mice at days 14 and 56 and eight mice at days 1 and 28, from two independent experiments. The difference between experimental
groups was evaluated by the two-tailed Student t test: P values, *P < 0.05, **P < 0.01, ***P < 0.005.









(Fig. 4B). The fact that M. canettii, which is an early-branching
representative in the MTBC phylogenetic tree (3), exhibits a similar
PhoPR control on espACD expression as M. tuberculosis strongly
supports the hypothesis that animal-adapted and M. africanum
L6 strains specifically acquired this property during evolution.
In line with these observations, transfer of the espACD allele
from M. bovis (espACD-bovis) into M. tuberculosis ΔphoPR increa-
ses espACD expression and restores ESAT-6 secretion, whereas
transfer of a second copy of the corresponding region from
M. tuberculosis (espACD-TB) has only marginal impact (Fig. 4 C
and D and Fig. S8). Overall, our results demonstrate that muta-
tions of the PhoPR system impair the production of mole-
cules, such as SL, PAT, and LipF, important for pathogenicity in
the animal-adapted and M. africanum L6 lineages. Nevertheless,
these strains acquired compensatory mutations that short-cut the
regulation loop controlling espACD expression in M. tuberculosis.
IS6110 Insertion Upstream phoPR in the Hypervirulent M. bovis B
Compensates the phoPR-bovis Deficiency. Despite the compensa-
tory genetic events affecting ESAT-6 secretion, epidemiological
data support the hypothesis that animal-adapted andM. africanum
L6 strains have not recovered the same virulence for humans as
M. tuberculosis sensu-stricto strains (likely because of the above-
mentioned expression differences in other members of the
PhoPR regulon). Thus, documented outbreaks of human TB
caused by strains from the animal-adapted lineage are extremely
rare. Of note, a unique multidrug-resistantM. bovis isolate,M. bovis
B, was responsible for 36 TB cases in Spain (35), where this specific
strain successfully spread via human-to-human transmission. In-
terestingly, thisM. bovis B isolate harbors a mobile element, IS6110,
inserted 75-bp upstream of the phoPR operon (36) (Fig. 5A). When
we transferred this particular phoPR allele fromM. bovis B (phoPR-
B) into M. tuberculosis ΔphoPR and M. bovis ΔphoPR, we found
increased phoP transcription and PhoP production in comparison
Fig. 3. The phoPR-bovis allele is deficient but ESAT-6 is secreted in animal-adapted strains. (A) qRT-PCR analysis of expression of main reporter genes of the PhoP
regulon in WT and recombinantM. bovis AN5 grown liquid culture. (B) TLC analysis of lipids extracted from [14C] propionic acid-labeled cultures. (C) Immunoblot
of secreted and whole-cell fractions from WT or recombinant M. bovis strains probed with ESAT-6– or GroEL2-specific antibodies.
Fig. 4. RD8 deletion allows ESAT-6 secretion independently from PhoPR. (A) Schematic representation of the genetic structure at the espACD locus in the
M. tuberculosis sensu-stricto and animal-adapted or M. africanum L6 strains. Red lines indicate individual SNPs identified between pairwise-compared
genomes. Blue lines indicate the boundaries of the RD8 deletion. (B) qRT-PCR analysis of espACD genes expression in five strains of the MTBC harboring
a ΔphoPR deletion. (C ) Immunoblot of secreted ESAT-6 from H37Rv WT, ΔphoPR mutant, and ΔphoPR mutant carrying the espACD fragment from
M. bovis (espACD-bovis) or the control similar fragment from H37Rv (espACD-TB). Several transformants were analyzed. The bacterial supernatants
and cell pellets were probed for ESAT-6 or GroEL2. (D) Quantification of the ESAT-6 signals in secreted protein fractions from the indicated strains
(relative to H37Rv).
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with WT (Fig. 5 B and C and Fig. S9). Consistently, we detected
increased transcription of PhoP regulon genes (Fig. 5D), production
of SL and PAT (Fig. 5E and Fig. S9), and ESAT-6 secretion in
the recombinant M. tuberculosis or M. bovis AN5 strains har-
boring the phoPR-B allele. Thus, the occurrence of IS6110 up-
stream phoPR globally compensates the deleterious effect of the
SNPs found in the phoPR-bovis allele, and this suppressive effect is
likely a result of increased expression of phoPR driven by a strong
IS6110-contained promoter (36, 37).
Finally, we sought to determine the impact of the IS6110 in-
sertion on virulence. Because we observed in our initial experi-
ments (Fig. 2 B and C) that the attenuation phenotype associated
with the phoPR-bovis allele was clearly seen in the acute phase of
infection in mice, we used for these experiments severe combined
immunodeficient (SCID) mice, which reproduce this initial phase
(38). Consistent with the phenotype in vitro, the phoPR-B allele
provides enhanced in vivo virulence in mice. Indeed, infection of
SCID mice showed the median survival times were similar for
M. tuberculosis strains expressing phoPR-TB (34 d) or phoPR-B
(30 d) and significantly higher for the recombinant strain ex-
pressing phoPR-bovis (43 d) or the ΔphoPR mutant (Fig. 5F).
Taking these data together, it seems very likely that the highly
virulent, human-to-human transmission-associated phenotype of the
M. bovis B strain is caused by the specific IS6110 insertion, which
suppresses the various phoPR-bovis–associated deficiencies.
Conclusions
In this study we demonstrated that the PhoPR regulation system
is deficient in animal-adapted andM. africanum strains primarily
because of a mutation within the phoR gene. The key role of
PhoPR for the M. tuberculosis pathogenicity was previously
established: a spontaneous punctual mutation altering the DNA-
binding capacity of PhoP in the H37Ra strain or insertional
inactivation of the phoP gene in two M. tuberculosis strains sig-
nificantly impaired the multiplication in mice or macrophages
(17, 18, 20, 21). Here, we found that specific mutations present
within the phoPR-bovis allele, when transferred intoM. tuberculosis,
also strongly impact the virulence of the recombinant strain, raising
important questions about the consequences of these mutations for
the evolutionary history of the concerned lineages of tubercle bacilli.
Overall, our results provide a molecular explanation for the
intriguing epidemiological data showing that M. bovis and other
animal-adapted strains are only rarely found in human TB out-
breaks, despite their close genetic relationship with M. tubercu-
losis sensu-stricto and their ability to infect humans through
contaminated milk. Our findings may also be extended to the
closely related M. africanum L6 strains, which exhibit a sim-
ilar impaired fitness relative to M. tuberculosis sensu-stricto
(13). Our results suggest an evolutionary scenario (Fig. S10) in
which mutations at the phoPR locus occurred in the common
ancestor of the animal-adapted and M. africanum strains. These
mutations impacted the synthesis and secretion of lipid- and
protein- pathogenicity factors, with the likely consequence of dra-
matically reduced fitness for the human host. The strains, which
successfully got through this low-virulence bottleneck, acquired
compensatory mutations, such as the RD8 deletion, that restored
the secretion of ESAT-6 via EspACD independently of phoPR but
still failed to provide the same virulence for humans as the ancestral
phoPR-TB allele. The animal-adapted strains may have acquired
later additional mutations, allowing them to persist in various ani-
mal species that might exhibit a different susceptibility than humans,
such as Mycobacterium microti in voles and cats (39), the Dassie
bacillus in dassies (40), Mycobacterium mungi in the banded mon-
gooses (41), Mycobacterium pinnipedii in seals (42), or M. bovis
in cattle, deer, and badgers (6). Of note, specific adaptation of
M. tuberculosis sensu-stricto to the human host seems to be
conversely associated with lower virulence than M. bovis strains
in certain animal species, such as rabbits, goats, or cattle (43–45).
Finally, in some exceptional animal-adapted isolates, such as
the M. bovis B strain, additional fitness for the human host
was gained through insertion of a mobile element upstream
phoPR, leading to overexpression of this operon, favoring
aerosol transmission of bacilli via patients who have developed
active pulmonary TB. This succession of genetic events is fully
Fig. 5. Insertion of IS6110 upstream phoPR in M. bovis B strain suppresses the phoPR-bovis deficiency. (A) Schematic representation of the genetic structure
at the phoPR locus in the M. bovis B strain relative to “classic” M. bovis and M. tuberculosis strains. The positions of SNPs specific to the animal-adapted and
M. africanum L6 and of the IS6110 insertion site are indicated in brackets. Red lines indicate individual SNPs identified between pairwise-compared genomes.
Blue lines indicate the boundaries of IS6110. (B) qRT-PCR analysis of phoPR expression in M. tuberculosis H37Rv strain, the ΔphoPR mutant, and the
recombinant M. tuberculosis strain expressing the phoPR-B allele. (C) Western blot analysis of PhoP from WT and phoPR-B expressing strains. (D) qRT-PCR
analysis of expression of PhoP regulon genes in the indicated strains. (E) TLC analysis of lipids extracted from [14C] propionic acid-labeled cultures. (F) Survival
of SCID mice infected with ∼4 × 103 cfu of the indicated strains (five mice per group). Curves are significantly different between the phoPR-bovis expressing
strain and the phoPR-TB– and phoPR-B–expressing strains (P < 0.005, according to the log-rank (Mantel– Cox) test).









compatible with previously proposed phylogenic schemes (1, 2,
46) and underlines how a few point mutations in important
genes, combined with selected compensatory mutations, can have
a long-lasting and powerful impact on the evolution and adapta-
tion of a pathogen to specific hosts.
Materials and Methods
Mutations in the variousM. tuberculosis sensu-stricto,M. bovis,M. africanum, or
M. canettii strains were performed by allelic exchange. The resulting mutants
were characterized by PCR using specific primers. The complemented strains
were produced by inserting a single copy of the indicated genes on the myco-
bacterial chromosome. Lipid analysis was performed on exponentially growing
strains labeled for 24 h with [14C] propionic acid or on stationary-phase bacteria
cultured as pellicles for mass spectrometry. RNA levels were determined by
quantitative real-time PCR using SYBR green and specific primers. Transcriptome
analyses were performed using Agilent manufactured customized microarrays
with RNA extracted from exponentially growing bacteria, labeled with Cy5 or
Cy3, and hybridized competitively. Western-blot of proteins secreted or associ-
ated with bacterial cells were performed on 3-wk-old cultures fractionated by
centrifugation before protein extraction, separation by SDS/PAGE, membrane
transfer, and hybridization with ESAT-6–, PhoP-, or GroEL2-specific antibodies.
Animal studies were conducted on 7-wk-old mice infected intranasally and
euthanized at various days postinfection for bacterial load evaluation in lung
and spleens. Human macrophages infection assays were carried out in human
monocyte-derived macrophages obtained from anonymous nontuberculous
donors and infected at multiplicity of infection 2 for 2 h with GFP-expressing
bacteria. Statistical analyses were performed using GraphPad Prism software.
A detailed materials and methods section is provided in the SI Materials
and Methods.
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